A letter from the Department of Justice to Rep. Earl Blumenauer reveals that DEA has received a recommendation from FDA as to whether marijuana should be rescheduled under federal law.
A letter from the Department of Justice to Rep. Earl Blumenauer reveals that DEA has received a recommendation from FDA as to whether marijuana should be rescheduled under federal law.
A letter from the Department of Justice to Rep. Earl Blumenauer reveals that DEA has received a recommendation from FDA as to whether marijuana should be rescheduled under federal law.